Table 1.
Patient characteristics
| Characteristics | S0-1 (n = 48) | S2 (n = 37) | S3 (n = 32) | S4 (n = 29) | P-value |
|---|---|---|---|---|---|
| Age (y) | 33.3 ± 13.1 | 33.5 ± 10.1 | 36.7 ± 6.9 | 46.5 ± 12.4 | < 0.001** |
| Sex(male/female) | 20/28 | 22/15 | 19/13 | 18/11 | < 0.001** |
| BMI (kg/m2) | 20.7 ± 2.5 | 22.5 ± 2.8 | 21.7 ± 3.5 | 21.8 ± 2.9 | < 0.001** |
| PLT (109/L) | 180.7 ± 59.6 | 161.5 ± 48.7 | 144.0 ± 45.1 | 96.9 ± 46.1 | < 0.001** |
| TB (µmol/L) | 9.8 ± 4.5 | 10.2 ± 3.6 | 10.6 ± 3.3 | 14.5 ± 5.7 | < 0.001** |
| ALT (IU/L) | 27.2 ± 19.0 | 32.8 ± 18.8 | 39.2 ± 18.9 | 44.9 ± 30.9 | 0.12 |
| AST (IU/L) | 23.2 ± 8.1 | 25.3 ± 9.0 | 29.1 ± 5.8 | 57.3 ± 49.8 | < 0.001** |
| GGT (IU/L) | 16.6 ± 9.5 | 19.9 ± 12.5 | 22.4 ± 7.1 | 82.3 ± 117.8 | < 0.001** |
| ALB (g/L) | 41.4 ± 2.9 | 40.1 ± 7.5 | 40.3 ± 2.8 | 36.9 ± 4.2 | 0.004** |
| HA (µg/L) | 75.0 (56.9–88.8) | 56.0 (44.2–95.3) | 28.3 (4.03–84.3) | 102.7 (68.5–188.3) | < 0.001** |
| Chol (mg/dL) | 3.8 ± 0.9 | 3.7 ± 0.9 | 3.6 ± 0.4 | 3.5 ± 0.7 | 0.442 |
| PT (sec) | 12.0 ± 0.95 | 12.6 ± 0.81 | 12.6 ± 0.88 | 13.7 ± 1.33 | 0.063 |
| PI (%) | 0.93 ± 0.07 | 0.97 ± 0.08 | 1.02 ± 0.13 | 0.92 ± 0.14 | 0.004** |
| α2-M | 8.6 ± 1.5 | 7.6 ± 1.4 | 8.2 ± 1.7 | 8.1 ± 1.2 | 0.047* |
| Urea (mmol/L) | 4.1 ± 1.0 | 4.2 ± 1.4 | 4.5 ± 1.2 | 4.4 ± 1.3 | 0.492 |
BMI = body mass index, ALT = alanine aminotransferase, AST = aspartate aminotransferase, PLT = Platelet, TB = total bilirubin, GGT = gamma-glutamyl transpeptidase, ALB = albumin, HA = hyaluronic acid, Chol = cholesterol, PI = prothrombin index, α2-M = α2-macroglobulin